These findings provide valuable insights for future research on PCM, particularly regarding the exploration of IL-6/JAK2/STAT3 pathway inhibitors and Bcl-2 inhibitors as potential therapeutic options. Here, JAK2 is linked to paracoccidioidomycosis.